期刊
HUMAN MUTATION
卷 32, 期 5, 页码 526-531出版社
WILEY
DOI: 10.1002/humu.21454
关键词
pharmacogenetics; database; personalized medicine; adverse drug reaction; cytochrome P450; transporter; polymorphism
资金
- Swedish Research Council
- Swedish Brain Foundation
- Swedish Cancer Fund
- NIH [GM61374]
In the area of pharmacogenetics and personalized health care it is obvious that databases, providing important information of the occurrence and consequences of variant genes encoding drug metabolizing enzymes, drug transporters, drug targets, and other proteins of importance for drug response or toxicity, are of critical value for scientists, physicians, and industry. The primary outcome of the pharmacogenomic field is the identification of biomarkers that can predict drug toxicity and drug response, thereby individualizing and improving drug treatment of patients. The drug in question and the polymorphic gene exerting the impact are the main issues to be searched for in the databases. Here, we review the databases that provide useful information in this respect, of benefit for the development of the pharmacogenomic field. Hum Mutat 32:526-531, 2011. (C) 2011 Wiley-Liss, Inc.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据